Home Healthcare Pharmaceuticals Immunotherapy Drugs Market

Immunotherapy Drugs Market Size, Share & Trends Analysis Report By Type (Monoclonal Antibodies, Vaccines, Immunomodulators), By Indication (Cancer, Autoimmune and Inflammatory Diseases, Infectious Diseases) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: February 12, 2026 | Author: Mitiksha Koul | Format: | Report Code: SR1192DR | Pages: 140
Overview TOC Segmentation Methodology
Download Free Sample

Market Segmentation

  1. Immunotherapy Drugs Market, By Type 2022-2034 (USD MILLION/ Units)
    1. Monoclonal Antibodies
    2. Vaccines
    3. Immunomodulators
  2. Immunotherapy Drugs Market, By Indication 2022-2034 (USD MILLION/ Units)
    1. Cancer
    2. Autoimmune and Inflammatory Diseases
    3. Infectious Diseases
  3. Regional Immunotherapy Drugs Market
    1. North America
      1. North America Immunotherapy Drugs Market By Type 2022-2034 (USD MILLION/ Units)
        1. Monoclonal Antibodies
        2. Vaccines
        3. Immunomodulators
      2. North America Immunotherapy Drugs Market By Indication 2022-2034 (USD MILLION/ Units)
        1. Cancer
        2. Autoimmune and Inflammatory Diseases
        3. Infectious Diseases
      3. U.S. Immunotherapy Drugs Market
        1. U.S. Immunotherapy Drugs Market By Type 2022-2034 (USD MILLION/ Units)
          1. Monoclonal Antibodies
          2. Vaccines
          3. Immunomodulators
        2. U.S. Immunotherapy Drugs Market By Indication 2022-2034 (USD MILLION/ Units)
          1. Cancer
          2. Autoimmune and Inflammatory Diseases
          3. Infectious Diseases
      4. Canada Immunotherapy Drugs Market
        1. Canada Immunotherapy Drugs Market By Type 2022-2034 (USD MILLION/ Units)
          1. Monoclonal Antibodies
          2. Vaccines
          3. Immunomodulators
        2. Canada Immunotherapy Drugs Market By Indication 2022-2034 (USD MILLION/ Units)
          1. Cancer
          2. Autoimmune and Inflammatory Diseases
          3. Infectious Diseases
    2. Europe
      1. Europe Immunotherapy Drugs Market By Type 2022-2034 (USD MILLION/ Units)
        1. Monoclonal Antibodies
        2. Vaccines
        3. Immunomodulators
      2. Europe Immunotherapy Drugs Market By Indication 2022-2034 (USD MILLION/ Units)
        1. Cancer
        2. Autoimmune and Inflammatory Diseases
        3. Infectious Diseases
      3. U.K. Immunotherapy Drugs Market
        1. U.K. Immunotherapy Drugs Market By Type 2022-2034 (USD MILLION/ Units)
          1. Monoclonal Antibodies
          2. Vaccines
          3. Immunomodulators
        2. U.K. Immunotherapy Drugs Market By Indication 2022-2034 (USD MILLION/ Units)
          1. Cancer
          2. Autoimmune and Inflammatory Diseases
          3. Infectious Diseases
      4. Germany Immunotherapy Drugs Market
        1. Germany Immunotherapy Drugs Market By Type 2022-2034 (USD MILLION/ Units)
          1. Monoclonal Antibodies
          2. Vaccines
          3. Immunomodulators
        2. Germany Immunotherapy Drugs Market By Indication 2022-2034 (USD MILLION/ Units)
          1. Cancer
          2. Autoimmune and Inflammatory Diseases
          3. Infectious Diseases
      5. France Immunotherapy Drugs Market
        1. France Immunotherapy Drugs Market By Type 2022-2034 (USD MILLION/ Units)
          1. Monoclonal Antibodies
          2. Vaccines
          3. Immunomodulators
        2. France Immunotherapy Drugs Market By Indication 2022-2034 (USD MILLION/ Units)
          1. Cancer
          2. Autoimmune and Inflammatory Diseases
          3. Infectious Diseases
      6. Spain Immunotherapy Drugs Market
        1. Spain Immunotherapy Drugs Market By Type 2022-2034 (USD MILLION/ Units)
          1. Monoclonal Antibodies
          2. Vaccines
          3. Immunomodulators
        2. Spain Immunotherapy Drugs Market By Indication 2022-2034 (USD MILLION/ Units)
          1. Cancer
          2. Autoimmune and Inflammatory Diseases
          3. Infectious Diseases
      7. Italy Immunotherapy Drugs Market
        1. Italy Immunotherapy Drugs Market By Type 2022-2034 (USD MILLION/ Units)
          1. Monoclonal Antibodies
          2. Vaccines
          3. Immunomodulators
        2. Italy Immunotherapy Drugs Market By Indication 2022-2034 (USD MILLION/ Units)
          1. Cancer
          2. Autoimmune and Inflammatory Diseases
          3. Infectious Diseases
      8. Russia Immunotherapy Drugs Market
        1. Russia Immunotherapy Drugs Market By Type 2022-2034 (USD MILLION/ Units)
          1. Monoclonal Antibodies
          2. Vaccines
          3. Immunomodulators
        2. Russia Immunotherapy Drugs Market By Indication 2022-2034 (USD MILLION/ Units)
          1. Cancer
          2. Autoimmune and Inflammatory Diseases
          3. Infectious Diseases
      9. Nordic Immunotherapy Drugs Market
        1. Nordic Immunotherapy Drugs Market By Type 2022-2034 (USD MILLION/ Units)
          1. Monoclonal Antibodies
          2. Vaccines
          3. Immunomodulators
        2. Nordic Immunotherapy Drugs Market By Indication 2022-2034 (USD MILLION/ Units)
          1. Cancer
          2. Autoimmune and Inflammatory Diseases
          3. Infectious Diseases
      10. Benelux Immunotherapy Drugs Market
        1. Benelux Immunotherapy Drugs Market By Type 2022-2034 (USD MILLION/ Units)
          1. Monoclonal Antibodies
          2. Vaccines
          3. Immunomodulators
        2. Benelux Immunotherapy Drugs Market By Indication 2022-2034 (USD MILLION/ Units)
          1. Cancer
          2. Autoimmune and Inflammatory Diseases
          3. Infectious Diseases
      11. Rest of Europe Immunotherapy Drugs Market
        1. Rest of Europe Immunotherapy Drugs Market By Type 2022-2034 (USD MILLION/ Units)
          1. Monoclonal Antibodies
          2. Vaccines
          3. Immunomodulators
        2. Rest of Europe Immunotherapy Drugs Market By Indication 2022-2034 (USD MILLION/ Units)
          1. Cancer
          2. Autoimmune and Inflammatory Diseases
          3. Infectious Diseases
    3. APAC
      1. APAC Immunotherapy Drugs Market By Type 2022-2034 (USD MILLION/ Units)
        1. Monoclonal Antibodies
        2. Vaccines
        3. Immunomodulators
      2. APAC Immunotherapy Drugs Market By Indication 2022-2034 (USD MILLION/ Units)
        1. Cancer
        2. Autoimmune and Inflammatory Diseases
        3. Infectious Diseases
      3. China Immunotherapy Drugs Market
        1. China Immunotherapy Drugs Market By Type 2022-2034 (USD MILLION/ Units)
          1. Monoclonal Antibodies
          2. Vaccines
          3. Immunomodulators
        2. China Immunotherapy Drugs Market By Indication 2022-2034 (USD MILLION/ Units)
          1. Cancer
          2. Autoimmune and Inflammatory Diseases
          3. Infectious Diseases
      4. Korea Immunotherapy Drugs Market
        1. Korea Immunotherapy Drugs Market By Type 2022-2034 (USD MILLION/ Units)
          1. Monoclonal Antibodies
          2. Vaccines
          3. Immunomodulators
        2. Korea Immunotherapy Drugs Market By Indication 2022-2034 (USD MILLION/ Units)
          1. Cancer
          2. Autoimmune and Inflammatory Diseases
          3. Infectious Diseases
      5. Japan Immunotherapy Drugs Market
        1. Japan Immunotherapy Drugs Market By Type 2022-2034 (USD MILLION/ Units)
          1. Monoclonal Antibodies
          2. Vaccines
          3. Immunomodulators
        2. Japan Immunotherapy Drugs Market By Indication 2022-2034 (USD MILLION/ Units)
          1. Cancer
          2. Autoimmune and Inflammatory Diseases
          3. Infectious Diseases
      6. India Immunotherapy Drugs Market
        1. India Immunotherapy Drugs Market By Type 2022-2034 (USD MILLION/ Units)
          1. Monoclonal Antibodies
          2. Vaccines
          3. Immunomodulators
        2. India Immunotherapy Drugs Market By Indication 2022-2034 (USD MILLION/ Units)
          1. Cancer
          2. Autoimmune and Inflammatory Diseases
          3. Infectious Diseases
      7. Australia Immunotherapy Drugs Market
        1. Australia Immunotherapy Drugs Market By Type 2022-2034 (USD MILLION/ Units)
          1. Monoclonal Antibodies
          2. Vaccines
          3. Immunomodulators
        2. Australia Immunotherapy Drugs Market By Indication 2022-2034 (USD MILLION/ Units)
          1. Cancer
          2. Autoimmune and Inflammatory Diseases
          3. Infectious Diseases
      8. Taiwan Immunotherapy Drugs Market
        1. Taiwan Immunotherapy Drugs Market By Type 2022-2034 (USD MILLION/ Units)
          1. Monoclonal Antibodies
          2. Vaccines
          3. Immunomodulators
        2. Taiwan Immunotherapy Drugs Market By Indication 2022-2034 (USD MILLION/ Units)
          1. Cancer
          2. Autoimmune and Inflammatory Diseases
          3. Infectious Diseases
      9. South East Asia Immunotherapy Drugs Market
        1. South East Asia Immunotherapy Drugs Market By Type 2022-2034 (USD MILLION/ Units)
          1. Monoclonal Antibodies
          2. Vaccines
          3. Immunomodulators
        2. South East Asia Immunotherapy Drugs Market By Indication 2022-2034 (USD MILLION/ Units)
          1. Cancer
          2. Autoimmune and Inflammatory Diseases
          3. Infectious Diseases
      10. Rest of Asia-Pacific Immunotherapy Drugs Market
        1. Rest of Asia-Pacific Immunotherapy Drugs Market By Type 2022-2034 (USD MILLION/ Units)
          1. Monoclonal Antibodies
          2. Vaccines
          3. Immunomodulators
        2. Rest of Asia-Pacific Immunotherapy Drugs Market By Indication 2022-2034 (USD MILLION/ Units)
          1. Cancer
          2. Autoimmune and Inflammatory Diseases
          3. Infectious Diseases
    4. Middle East and Africa
      1. Middle East and Africa Immunotherapy Drugs Market By Type 2022-2034 (USD MILLION/ Units)
        1. Monoclonal Antibodies
        2. Vaccines
        3. Immunomodulators
      2. Middle East and Africa Immunotherapy Drugs Market By Indication 2022-2034 (USD MILLION/ Units)
        1. Cancer
        2. Autoimmune and Inflammatory Diseases
        3. Infectious Diseases
      3. UAE Immunotherapy Drugs Market
        1. UAE Immunotherapy Drugs Market By Type 2022-2034 (USD MILLION/ Units)
          1. Monoclonal Antibodies
          2. Vaccines
          3. Immunomodulators
        2. UAE Immunotherapy Drugs Market By Indication 2022-2034 (USD MILLION/ Units)
          1. Cancer
          2. Autoimmune and Inflammatory Diseases
          3. Infectious Diseases
      4. Turkey Immunotherapy Drugs Market
        1. Turkey Immunotherapy Drugs Market By Type 2022-2034 (USD MILLION/ Units)
          1. Monoclonal Antibodies
          2. Vaccines
          3. Immunomodulators
        2. Turkey Immunotherapy Drugs Market By Indication 2022-2034 (USD MILLION/ Units)
          1. Cancer
          2. Autoimmune and Inflammatory Diseases
          3. Infectious Diseases
      5. Saudi Arabia Immunotherapy Drugs Market
        1. Saudi Arabia Immunotherapy Drugs Market By Type 2022-2034 (USD MILLION/ Units)
          1. Monoclonal Antibodies
          2. Vaccines
          3. Immunomodulators
        2. Saudi Arabia Immunotherapy Drugs Market By Indication 2022-2034 (USD MILLION/ Units)
          1. Cancer
          2. Autoimmune and Inflammatory Diseases
          3. Infectious Diseases
      6. South Africa Immunotherapy Drugs Market
        1. South Africa Immunotherapy Drugs Market By Type 2022-2034 (USD MILLION/ Units)
          1. Monoclonal Antibodies
          2. Vaccines
          3. Immunomodulators
        2. South Africa Immunotherapy Drugs Market By Indication 2022-2034 (USD MILLION/ Units)
          1. Cancer
          2. Autoimmune and Inflammatory Diseases
          3. Infectious Diseases
      7. Egypt Immunotherapy Drugs Market
        1. Egypt Immunotherapy Drugs Market By Type 2022-2034 (USD MILLION/ Units)
          1. Monoclonal Antibodies
          2. Vaccines
          3. Immunomodulators
        2. Egypt Immunotherapy Drugs Market By Indication 2022-2034 (USD MILLION/ Units)
          1. Cancer
          2. Autoimmune and Inflammatory Diseases
          3. Infectious Diseases
      8. Nigeria Immunotherapy Drugs Market
        1. Nigeria Immunotherapy Drugs Market By Type 2022-2034 (USD MILLION/ Units)
          1. Monoclonal Antibodies
          2. Vaccines
          3. Immunomodulators
        2. Nigeria Immunotherapy Drugs Market By Indication 2022-2034 (USD MILLION/ Units)
          1. Cancer
          2. Autoimmune and Inflammatory Diseases
          3. Infectious Diseases
      9. Rest of MEA Immunotherapy Drugs Market
        1. Rest of MEA Immunotherapy Drugs Market By Type 2022-2034 (USD MILLION/ Units)
          1. Monoclonal Antibodies
          2. Vaccines
          3. Immunomodulators
        2. Rest of MEA Immunotherapy Drugs Market By Indication 2022-2034 (USD MILLION/ Units)
          1. Cancer
          2. Autoimmune and Inflammatory Diseases
          3. Infectious Diseases
    5. LATAM
      1. LATAM Immunotherapy Drugs Market By Type 2022-2034 (USD MILLION/ Units)
        1. Monoclonal Antibodies
        2. Vaccines
        3. Immunomodulators
      2. LATAM Immunotherapy Drugs Market By Indication 2022-2034 (USD MILLION/ Units)
        1. Cancer
        2. Autoimmune and Inflammatory Diseases
        3. Infectious Diseases
      3. Brazil Immunotherapy Drugs Market
        1. Brazil Immunotherapy Drugs Market By Type 2022-2034 (USD MILLION/ Units)
          1. Monoclonal Antibodies
          2. Vaccines
          3. Immunomodulators
        2. Brazil Immunotherapy Drugs Market By Indication 2022-2034 (USD MILLION/ Units)
          1. Cancer
          2. Autoimmune and Inflammatory Diseases
          3. Infectious Diseases
      4. Mexico Immunotherapy Drugs Market
        1. Mexico Immunotherapy Drugs Market By Type 2022-2034 (USD MILLION/ Units)
          1. Monoclonal Antibodies
          2. Vaccines
          3. Immunomodulators
        2. Mexico Immunotherapy Drugs Market By Indication 2022-2034 (USD MILLION/ Units)
          1. Cancer
          2. Autoimmune and Inflammatory Diseases
          3. Infectious Diseases
      5. Argentina Immunotherapy Drugs Market
        1. Argentina Immunotherapy Drugs Market By Type 2022-2034 (USD MILLION/ Units)
          1. Monoclonal Antibodies
          2. Vaccines
          3. Immunomodulators
        2. Argentina Immunotherapy Drugs Market By Indication 2022-2034 (USD MILLION/ Units)
          1. Cancer
          2. Autoimmune and Inflammatory Diseases
          3. Infectious Diseases
      6. Chile Immunotherapy Drugs Market
        1. Chile Immunotherapy Drugs Market By Type 2022-2034 (USD MILLION/ Units)
          1. Monoclonal Antibodies
          2. Vaccines
          3. Immunomodulators
        2. Chile Immunotherapy Drugs Market By Indication 2022-2034 (USD MILLION/ Units)
          1. Cancer
          2. Autoimmune and Inflammatory Diseases
          3. Infectious Diseases
      7. Colombia Immunotherapy Drugs Market
        1. Colombia Immunotherapy Drugs Market By Type 2022-2034 (USD MILLION/ Units)
          1. Monoclonal Antibodies
          2. Vaccines
          3. Immunomodulators
        2. Colombia Immunotherapy Drugs Market By Indication 2022-2034 (USD MILLION/ Units)
          1. Cancer
          2. Autoimmune and Inflammatory Diseases
          3. Infectious Diseases
      8. Rest of LATAM Immunotherapy Drugs Market
        1. Rest of LATAM Immunotherapy Drugs Market By Type 2022-2034 (USD MILLION/ Units)
          1. Monoclonal Antibodies
          2. Vaccines
          3. Immunomodulators
        2. Rest of LATAM Immunotherapy Drugs Market By Indication 2022-2034 (USD MILLION/ Units)
          1. Cancer
          2. Autoimmune and Inflammatory Diseases
          3. Infectious Diseases
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.